US 12162861
Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
granted A61PA61P25/18A61P25/24
Quick answer
US patent 12162861 (Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P25/18, A61P25/24, A61P25/36